Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2016
Inclusion of elderly patients in oncology clinical trialsO Le Saux, C Falandry, H K Gan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Changes in the use of end points in clinical trials for elderly cancer patients over timeO Le Saux, C Falandry, H K Gan, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|April 15, 2008
Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trialP Heudel, P Romestaing, N Barbet, et al.European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Trends in tobacco smoking among adolescents in Lyon, FranceA J Sasco, R M Merrill, V Benhaïm-Luzon, et al.IET Systems Biology|May 20, 2009
Chemotherapy may be delivered based on an integrated view of tumour dynamicsB Ribba, B You, M Tod, et al.Revue Des Maladies Respiratoires|January 1, 1996
[Chemotherapy in elderly patients with bronchogenic cancers]P J Souquet, C H Lombard-Bohas, G Freyer, et al.Gene|June 19, 1998
Characterization of the human mitochondrial aconitase gene (ACO2)D B Mirel, K Marder, J Graziano, et al.Neurology|September 26, 1997
Altered systemic iron metabolism in Parkinson's diseaseG Logroscino, K Marder, J Graziano, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Dietary iron, animal fats, and risk of Parkinson's diseaseG Logroscino, K Marder, J Graziano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trialG Freyer, N Bossard, P Romestaing, et al.Pageof 8